Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hebei
Clinical trial register · China

Clinical Trials in Hebei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Hebei

22 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Brise Pharmaceuticals Co., Ltd.
Phase 3
1,000
Shanxi, Inner Mongolia, Beijing, Anhui, Hebei, Jilin City, Hunan, Chongqing
2026-09-30
Recruiting
Brise Pharmaceuticals Co., Ltd.
Phase 2/3
2,079
Shanxi, Inner Mongolia, Beijing, Anhui, Hebei, Jilin City, Hunan, Chongqing
2026-09-30
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
86
Hebei
2026-09-02
Not yet open
Hebei Medical University Fourth Hospital
Phase 2
32
Hebei
2026-09-01
Not yet open
A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension
NCT07833098Hypertension, Resistant Hypertension, Uncontrolled Hypertension
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 2
240
Baotou, Beijing, Changsha, Chengdu, Chongqing, Daqing, Hebei, Hengyang
2026-09
Recruiting
Phase III Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
NCT07860216Assessing the Effectiveness of Vaccines in Preventing Adult RSV-caused Lower Respiratory Tract Disease (LRTD)
Beijing BeneWill Technology Development Co., Ltd
Phase 3
25,000
GuiZhou, Hebei, HuBei, HuNan, Shandong, Shanxi, Baoshan
2026-08-21
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
30
Hebei
2026-08-01
Not yet open
CLASSYS Inc.
Not applicable
252
Chengdu, Chongqing, Hebei, Shanghai
2026-06
Not yet open
Beijing Hospital of Traditional Chinese Medicine
Phase 3
636
Beijing, Chengdu, Chongqing, Guangzhou, Guizhou, Haozhou, Hebei, Heilongjiang
2026-05-31
Recruiting
Shanghai Virogin Biotech Co., Ltd.
Phase 1
30
Hebei
2026-03-18
Not yet open
Ruijin Hospital
Phase 2
66
Beijing, Guangzhou, Shenzhen, Hebei, Zhengzhou, Wuhan, Changsha, Nanjing
2025-08-31
Recruiting
China Colorectal Cancer Screening Trial 1 (C-Cost1)
NCT07090291Colorectal Cancer, Advanced Adenoma
Zhejiang University
Not applicable
60,300
Guandong, Guangdong, Hebei, Nanjing, Shanghai, Sichuan, Zhejiang
2025-08-08
Not yet open
Universiti Tunku Abdul Rahman
Observational
158
Hebei
2025-06-23
Recruiting
School-Based Intervention to Enhance Resilience and Stress Coping in Rural Chinese Adolescents
NCT07115186Stress, Emotional, Stress-related Mental Disorders
Peking University
Not applicable
850
Hebei
2025-05-12
Recruiting
Shanghai Pushi Medical Science Co. Ltd
Phase 1
66
Beijing, Fujian, Zhejiang, Heilongjiang, Shandong, Guangdong, Shenyang, Hebei
2025-02-24
Recruiting
Daiichi Sankyo
Observational
150
Beijing, Changsha, Fuzhou, Guangdong, Guangzhou, Hangzhou, Hebei, Hefei
2025-02-21
Recruiting
The Second Hospital of Hebei Medical University
Not applicable
39
Hebei
2025-01-17
Recruiting
A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT06820268B-cell Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
168
Beijing, Guangdong, Hebei, Hubei
2025-01-14
Active, closed
AstraZeneca
Observational
1,199
Beijing, Chengdu, Fuzhou, Guangzhou, Guiyang, Harbin, Hebei, Henan
2024-09-26
Recruiting
A Prognostic Model for Drug-induced Liver Injury in China
NCT05060289Drug-induced Liver Injury
Beijing Friendship Hospital
Observational
3,000
Beijing, Dalian, Guangxi, Hebei, Jiaozuo, Lanzhou, Qingdao, Qinghai
2022-05-25
Active, closed
Sanofi
Phase 4
1,339
Beijing, Dongguan, Guangzhou, Guiyang, Hebei, Hefei, Nanchang, Nanjing
2021-12-16
Active, closed
Nanfang Hospital, Southern Medical University
Observational
1,300
Chongqing, Guangzhou, Hebei, Changsha, Nanjing, Xuzhou, Nanchang, Changchun
2021-09-15
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/hebei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Hebei.

How many clinical trials are recruiting in Hebei?

11 of the 22 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 8 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hebei), 22 studies
PhaseStudiesRecruitingShare
Observational5222.7%
Not applicable4318.2%
Phase 14318.2%
Phase 24118.2%
Phase 33113.6%
Phase 2/3114.5%
Phase 4104.5%

Most active sponsors

Lead sponsors with the most studies (Hebei)
Lead sponsorStudiesRecruiting
Brise Pharmaceuticals Co., Ltd.21
Cancer Institute and Hospital, Chinese Academy of Medical Sciences21
AstraZeneca10
Beijing BeneWill Technology Development Co., Ltd11
Beijing Friendship Hospital11
Beijing Hospital of Traditional Chinese Medicine10
CLASSYS Inc.10
Daiichi Sankyo11
Hebei Medical University Fourth Hospital10
Nanfang Hospital, Southern Medical University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.